Opportunistic viral infections were investigated in 156 adult patients admitted over one year to a medical oncology service: 35% of the total group and 65% of those with acute leukaemia experienced viral infections, 79% of which were with viruses of the herpes group. Surprisingly few enteric viruses were recovered. Reactivation of herpes simplex virus in the brains of these immunosuppressed patients was suggested by the demonstration by nucleic acid hybridization of herpes simplex virus DNA sequences in neurones and endothelial cells in patients with evidence of past infection with virus. Acyclovir was effective in therapy and prophylaxis. Twenty-three strains from 7 patients were tested for sensitivity to this antiviral: in 3 instances clinical resistance was observed but the strains were fully sensitive in vitro, as were all other strains tested.
Introduction
The increased risk of opportunistic infection in patients undergoing cytotoxic chemotherapy is well known (Aston et al. 1972 , Lam et al. 1981 . We describe the prevalence of viral infections in a group of patients receiving such therapy and draw attention to some newly recognized facets of these infections and of their management.
Methods
Opportunistic infections: One hundred and fifty-six patients were studied. They had been admitted to the medical oncology service of the Christie Hospital over one year, their diagnoses being mostly acute myeloid or lymphoblastic leukaemia (37), non-Hodgkin's lymphoma (25) or carcinoma of the bronchus (34) or breast (17) . Viral infections were sought for in patients with unexplained fever, sore mouths or oral ulceration, skin lesions or other suggestive symptomatology. Patients with leukaemia undergoing cytotoxic chemotherapy were also subjected to routine virological surveillance.
Post-mortem material from patients dying without malignant disease and who had not been immunosuppressed was made available through the kind offices of Professor B E Tomlinson, Department of Pathology, Newcastle General Hospital, Newcastle upon Tyne.
Standard methods (Anderson et al. 1984b ) were employed for the detection of virus infections by electronmicroscopy, by isolation in tissue culture and by serological tests.
Herpes simplex virus genome in brain tissue: 3H-labelled herpes simplex virus (HSV) type 1 DNA probes were prepared by nick translation of purified virus DNA and used in in situ nucleic acid hybridization tests, using a modification (Saldanha, Sutton & Itzhaki, in preparation) of the method of MacGregor & Varley (1983) . Essentially similar methods were 'Based on paper read to Section of Oncology, 9 May 1984. used for the preparation of an SV40 DNA probe in the detection of SV40 DNA sequences by solution hybridization.
Acyclovir in immunosuppressed patients: The criteria for the use of acyclovir in therapeutic intervention were ultimately clinical although laboratory investigations were freely used in the support of diagnosis. The sensitivities of strains of HSV to acyclovir were determined by a plaque reduction assay in Vero cells. This method was slightly modified from that of Field et al. (1980) .
Results
Opportunistic infections: A total of 668 specimens from 156 inpatients were tested; 55 of these 156 patients (35%) and 24 of 37 patients with acute leukaemia (65%) experienced viral infections. The results of virus investigations are given in Table 1 ; in addition, 26 of 90 patients (29%) showed serological evidence of virus infection. Most of these episodes (69 of 87: 79%) were with viruses of the herpes group, 57 of 69 being with HSV or varicella zoster and 12 with cytomegalovirus or Epstein-Barr viruses.
One strain of echo 19 virus was recovered from 10 faecal specimens taken from this group of patients during the study period. An additional, random sample of 459 faecal specimens from an additional 150 patients on the unit with the same array of diagnoses, tested by electronmicroscopy (168) and by tissue culture inoculation (453), yielded 6 strains identified by electronmicroscopy (calicivirus, 3 strains from one patient; one rotavirus; one coronavirus; and one small, unstructured, round virus) and 3 viruses identified in tissue culture (one adenovirus 1; one echo 22; and one unidentifiable enterovirus).
Of 34 patients with sore mouths, 13 had proved HSV infections; of 10 leukaemic patients with oral ulcers or soreness, 8 had proved herpes virus infections. Of 34 patients with skin lesions who were tested, 15 had proved virus infections (44%), 10 being with HSV and 5 with varicella zoster viruses. Both electronmicroscopy and tissue culture were used in diagnosis, partly because of false-negative results when only one technique was used and partly (using tissue culture) to secure virus strains for testing in the event of resistance to acyclovir treatment.
Herpes simplex virus genome in brain tissue: Brain tissue from 7 patients who died whilst immunocompromised (including 2 who received total body irradiation as part of a bone marrow transplant procedure), from 4 non-immunocompromised patients and from one patient with HSV encephalitis was investigated for evidence of HSV genome.
Using a radioactive labelled virus DNA probe, matching DNA sequences were detected in neural tissue and also in endothelial cells from temporal lobe tissue (Figure 1 ). These HSV DNA sequences were found in tissue from patients with evidence of past herpetic infection, as shown by the presence of antibodies to HSV. Reactivation of virus in the mouth and perioral area had also been demonstrated in life in 60% of these patients. Similar sequences were not found in immunosuppressed patients without evidence of past infection or in nonimmunosuppressed patients (in whom no evidence was available of past infection or of episodes of reactivation). Matching DNA sequences were detected in one patient with clinical and pathological evidence of acute HSV encephalitis (although infectious virus was not recovered post-mortem from brain tissue). This patient had not received acyclovir. These data are summarized in Table 2 . A similar radioactive labelled DNA probe was prepared from commercially available SV40 DNA (Bethesda Research Laboratories Inc (UK), Cambridge). Representative brain specimens which had already been tested for the presence of HSV DNA sequences were tested for SV40 DNA sequences; all yielded negative or, at best, equivocal results. Acyclovir in immunosuppressed patients: Twenty-one patients were treated with 28 courses of intravenous acyclovir, the indications being shingles (7), cold sores with or without pyrexia (6), mouth ulcers (6), chickenpox (4) and a variety of other indications (5). The dosage was (101)) 31.62 * ED50 in pg/ml 5 g/kg three times daily (for HSV infections) and 10 g/kg three times daily (for varicella zoster infections). Ten of 14 HSV infections responded and symptomatic improvement was noted in 9 of 10 courses given for varicella zoster infection. Two courses were given for Epstein-Barr virus infection with apparent response in one instance. On three occasions in 2 patients apparent resistance to acyclovir was noted, in that either lesions did not regress (2) or a higher dose was required to procure a satisfactory clinical response (1). Adverse affects were not prominent. Two courses were given to one patient during early pregnancy with no effect upon the infant, who was well and healthy at six months of age. One course (at 5 g/kg/day) was given uneventfully to a patient with severe renal failure. Two patients developed peripheral neuropathy, possibly related to acyclovir or to some other component of their chemotherapeutic regimens.
With any new antimicrobial, the probability of resistance arises. Twenty-three strains of HSV recovered from 7 patients in this study were tested for in vitro sensitivity to acyclovir (Table 3) . Although the degree of sensitivity varied, all strains were very much more sensitive than a standard thymidine kinase deficient (TK -ve) strain. In the three instances where clinical resistance was evident, all the strains recovered from the 2 patients were completely sensitive in vitro.
Discussion
Virus infections are common in the immunosuppressed and the intense surveillance to which our patients were subjected resulted in the detection of as many episodes as possible. We were therefore surprised at the low incidence of enterovirus infections, particularly in view of previous reports (Yolkden et al. 1982) .
HSV infections were common and attention should be drawn to the high proportion of patients with sore mouths or oral ulcers where this virus was recovered; many sore mouths which at present are attributed to chemotherapy may be associated with HSV infection.
The detection of HSV genome in brain tissue from immunocompromised patients is of concern, both for the individuals and more generally. HSV genome has previously been demonstrated in human brain tissue (Sequiera et al. 1979 , Fraser et al. 1981 ) and experimental immunosuppression of mice bearing latent HSV infections leads to virus reactivation in the brain (Kastrukoff et al. 1981) . HSV is certainly neurotropic, and recovery from proven HSV encephalitis may be associated with severe memory defects. In these immunosuppressed patients, is the presence of HSV genome in neural cells, in the absence of frank encephalitis, also associated with the possibility of neuropsychiatric disturbance? If so, then this might be important for long-term bone marrow transplant survivors.
Not all immunosuppression is iatrogenic or associated with debilitating disease. Minor degrees of immunosuppression may occur in otherwise healthy individuals, as in acute virus infections. This transient immunosuppression is well recognized during infectious : mononucleosis (Haider et al. 1973 ) and has been convincingly demonstrated during asymptomatic Epstein-Barr virus infection (Bowen et al. 1983 ). Would such temporary immunological dysfunction also permit HSV reactivation within the central nervous system, with the possibility of direct or indirect brain cell damage?
We failed to detect SV40 virus genome in brain tissue. SV40 is close to JC virus (Gannicliffe & Sutton 1982) which is widely prevalent and may be neurotropic, particularly in immunosuppressed individuals (as in AIDS, where reactivation of JC virus may result in the development of progressive multifocal leukoencephalopathy: Ho et al. 1984) . We cannot exclude the possibility that a specific (cloned) JC virus DNA probe might have demonstrated JC virus genome reactivation. It is fortunate that most viral infections in the immunosuppressed group under investigation were with viruses of the herpes group. Acyclovir is an effective, non-toxic antiviral (Brigden & Sutton 1983 ) which we used in treatment and in prophylaxis (Anderson et al. 1984a, b) . It was effective in the treatment of established infections with viruses of the herpes group. Our observation that some strains were apparently resistant in vivo but not in vitro is interesting and is in line with similar observations made by the Seattle team (Wade et al. 1983 ).
This effectiveness of intravenous acyclovir in the therapy of acute reactivations of HSV infection prompted a trial of prophylactic oral acyclovir versus placebo in a series of patients undergoing cytotoxic chemotherapy for the treatment of acute lymphoblastic leukaemia and non-Hodgkin's lymphoma (Anderson et al. 1984a ). The trial was double-blind and patients in the placebo arm were rescued with intravenous acyclovir if this became necessary. The results of this trial (Figure 2) indicate the effectiveness of oral acyclovir in this role.
The scope for control of opportunistic viral infections in immunosuppressed patients will doubtless increase. There are new antivirals which have not yet been fully evaluated in the clinical environment (e.g. Ribavirinpotent against RNA viruses; and two new compounds of potential use against cytomegalovirus infection -Foscarnet and BWB759U: Tyms et al. 1984) . These developments in therapy spur on the development of more rapid means of diagnosis, particularly in the detection of cytomegalovirus and Epstein-Barr virus reactivations. The development of therapeutic strategies directed towards latent virus infections is also given an incentive, not least by the detection of viral DNA in brain tissue.
Addendum: In one immunocompromised patient, on almost continuous acyclovir therapy over several months, acyclovir resistance (100-fold increase) has emerged. Restriction endonuclease analysis suggests that the resistant HSV strains are of the same subtype as the sensitive strains recovered from the same patient.
